These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7960957)

  • 1. HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection.
    Puppo F; Pellicci R; Brenci S; Nocera A; Morelli N; Dardano G; Bertocchi M; Antonucci A; Ghio M; Scudeletti M
    Hum Immunol; 1994 Jul; 40(3):166-70. PubMed ID: 7960957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
    Koelman CA; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
    Transpl Immunol; 2000 Mar; 8(1):57-64. PubMed ID: 10834611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation.
    Luque J; Torres MI; Aumente MD; Lozano JM; García-Jurado G; González R; Alvarez-López MR; Arizón JM; Peña J
    Transpl Immunol; 2006 Dec; 17(1):70-3. PubMed ID: 17157221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
    Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation.
    Filaci G; Contini P; Brenci S; Lanza L; Scudeletti M; Indiveri F; Puppo F
    Tissue Antigens; 1995 Aug; 46(2):117-23. PubMed ID: 7482504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome.
    DeVito-Haynes LD; Jankowska-Gan E; Meyer KC; Cornwell RD; Zeevi A; Griffith B; Dauber J; Iacono A; Burlingham WJ; Love RB
    Hum Immunol; 2000 Dec; 61(12):1370-82. PubMed ID: 11163095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance.
    Minguela A; Torío A; Marín L; Muro M; Villar LM; Díaz J; Ramírez P; Parrilla P; García-Alonso AM; Alvarez-López MR
    Hum Immunol; 1999 Jun; 60(6):500-9. PubMed ID: 10408799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
    Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I.
    DeVito-Haynes LD; Jankowska-Gan E; Sollinger HW; Knechtle SJ; Burlingham WJ
    Hum Immunol; 1994 Jul; 40(3):191-201. PubMed ID: 7960963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients.
    Borelli SD; Ferreira E; Oliveira AM; Krishnaswamy S; Hiraki DD; Grumet FC
    Hum Immunol; 1999 May; 60(5):430-4. PubMed ID: 10447402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver, and small bowel-plus-liver transplant recipients.
    Satoh S; Thomson AW; Nakamura K; Warty V; Todo S
    Transplantation; 1995 Sep; 60(6):558-62. PubMed ID: 7570951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
    Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
    Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble HLA-G expression and renal graft acceptance.
    Qiu J; Terasaki PI; Miller J; Mizutani K; Cai J; Carosella ED
    Am J Transplant; 2006 Sep; 6(9):2152-6. PubMed ID: 16780545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of perioperative sHLA I concentrations on the histological development of the liver graft.
    Müller J; Schenk M; Zipfel A; Lauchart W; Viebahn R
    Transpl Int; 2000; 13 Suppl 1():S449-51. PubMed ID: 11112051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble human leukocyte antigen-G (SHLA-G) in Tunisian kidney transplantation.
    Bardi R; Sfar I; Aounallah-Skhiri H; Kallala C; Abderrahim E; Ben Abdallah T; Gorgi Y
    Arch Inst Pasteur Tunis; 2011; 88(1-4):42-6. PubMed ID: 23461142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of soluble HLA class I size variants after liver transplantation.
    Rebmann V; Pässler M; Erhard J; Lange R; Eigler FW; Grosse-Wilde H
    Hum Immunol; 1999 May; 60(5):424-9. PubMed ID: 10447401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA antibodies interfere in the detection of soluble HLA class I molecules.
    Koelman CA; Ensink W; Mulder A; Tanke J; Doxiadis II; Claas FH
    Hum Immunol; 1999 May; 60(5):414-23. PubMed ID: 10447400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.